166 related articles for article (PubMed ID: 31105285)
1. Assessment of biofilm formation by pseudomonas aeruginosa and hydrodynamic evaluation of microtiter plate assay.
Samad A; Khan AA; Sajid M; Zahra R
J Pak Med Assoc; 2019 May; 69(5):666-671. PubMed ID: 31105285
[TBL] [Abstract][Full Text] [Related]
2. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections.
Hou W; Sun X; Wang Z; Zhang Y
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5624-31. PubMed ID: 22736609
[TBL] [Abstract][Full Text] [Related]
3. Microtiter dish biofilm formation assay.
O'Toole GA
J Vis Exp; 2011 Jan; (47):. PubMed ID: 21307833
[TBL] [Abstract][Full Text] [Related]
4. Optimization of tetrazolium salt assay for Pseudomonas aeruginosa biofilm using microtiter plate method.
Sabaeifard P; Abdi-Ali A; Soudi MR; Dinarvand R
J Microbiol Methods; 2014 Oct; 105():134-40. PubMed ID: 25086178
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection of different virulence factors genes harbor pslA, pelA, exoS, toxA and algD among biofilm-forming clinical isolates of Pseudomonas aeruginosa.
Farhan RE; Solyman SM; Hanora AM; Azab MM
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):32-39. PubMed ID: 37571905
[TBL] [Abstract][Full Text] [Related]
6. A colorimetric microtiter plate method for assessment of phage effect on Pseudomonas aeruginosa biofilm.
Knezevic P; Petrovic O
J Microbiol Methods; 2008 Aug; 74(2-3):114-8. PubMed ID: 18433900
[TBL] [Abstract][Full Text] [Related]
7. Macroscale versus microscale methods for physiological analysis of biofilms formed in 96-well microtiter plates.
Gomes LC; Moreira JM; Miranda JM; Simões M; Melo LF; Mergulhão FJ
J Microbiol Methods; 2013 Dec; 95(3):342-9. PubMed ID: 24140575
[TBL] [Abstract][Full Text] [Related]
8. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
[TBL] [Abstract][Full Text] [Related]
10. Relationship Among Antibiotic Resistance, Biofilm Formation and lasB Gene in Pseudomonas Aeruginosa Isolated from Burn Patients.
Roshani-Asl P; Rashidi N; Shokoohizadeh L; Zarei J
Clin Lab; 2018 Sep; 64(9):1477-1484. PubMed ID: 30274028
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of biofilm-specific antimicrobial resistance genes in Pseudomonas aeruginosa isolates in Farabi Hospital.
Saffari M; Karami S; Firoozeh F; Sehat M
J Med Microbiol; 2017 Jul; 66(7):905-909. PubMed ID: 28721848
[TBL] [Abstract][Full Text] [Related]
12. Association between Biofilm Formation and Antimicrobial Resistance in Carbapenem-Resistant
Cho HH; Kwon KC; Kim S; Park Y; Koo SH
Ann Clin Lab Sci; 2018 May; 48(3):363-368. PubMed ID: 29970441
[TBL] [Abstract][Full Text] [Related]
13. Association of biofilm formation with multi drug resistance in clinical isolates of
Abdulhaq N; Nawaz Z; Zahoor MA; Siddique AB
EXCLI J; 2020; 19():201-208. PubMed ID: 32256266
[No Abstract] [Full Text] [Related]
14. Evaluation of the biofilm-forming ability and genetic typing for clinical isolates of Pseudomonas aeruginosa by enterobacterial repetitive intergenic consensus-based PCR.
Yang W; Shi L; Jia WX; Yin X; Su JY; Kou Y; Yi X; Shinoda S; Miyoshi S
Microbiol Immunol; 2005; 49(12):1057-61. PubMed ID: 16365530
[TBL] [Abstract][Full Text] [Related]
15. Application of Phenotype Microarray for Profiling Carbon Sources Utilization between Biofilm and Non-Biofilm of Pseudomonas aeruginosa from Clinical Isolates.
Ismail NS; Subbiah SK; Taib NM
Curr Pharm Biotechnol; 2020; 21(14):1539-1550. PubMed ID: 32598252
[TBL] [Abstract][Full Text] [Related]
16. [Quantification for biofilm formation of pseudomonas aeruginosa isolates and their genotypic analysis].
Cheng X; Yang WQ; Shi L; Yin XL; Xie Y; Zeng W; Li XH; Su JY; Kou YL; Jia WX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):666-9. PubMed ID: 17037723
[TBL] [Abstract][Full Text] [Related]
17. Biofilm formation by clinically isolated Staphylococcus Aureus from India.
Triveni AG; Suresh Kumar M; Manjunath C; Shivannavar CT; Gaddad SM
J Infect Dev Ctries; 2018 Dec; 12(12):1062-1066. PubMed ID: 32027606
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.
Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M
Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of lactoferrin on biofilm formation in clinical isolates of Pseudomonas aeruginosa.
Kamiya H; Ehara T; Matsumoto T
J Infect Chemother; 2012 Feb; 18(1):47-52. PubMed ID: 21866304
[TBL] [Abstract][Full Text] [Related]
20. Assessment of biofilm removal capacity of a broad host range bacteriophage JHP against Pseudomonas aeruginosa.
Shafique M; Alvi IA; Abbas Z; Ur Rehman S
APMIS; 2017 Jun; 125(6):579-584. PubMed ID: 28418081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
